Amyris

Amyris P/B

Delisted·May 7, 2024

P/B (Price-to-Book Ratio) of Amyris (AMRSQ) as of Oct 8, 2026.

P/B

-0.00

YoY

-151.98%

Last updated:

P/B (Price-to-Book Ratio) of Amyris is 2022 -0.00 . P/B (Price-to-Book Ratio) of Amyris was 2021 0.00 . It decreases by -151.98% lower compared to the previous year.

The Amyris P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2015
-0.00 USD
Jan 1, 2016
-0.00 USD
Jan 1, 2017
-0.00 USD
Jan 1, 2018
-0.00 USD
Jan 1, 2019
-0.00 USD
Jan 1, 2020
-0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
-0.00 USD
The Amyris P/B history
YEARP/BYoY
-0.00-151.98%
0.00-168.33%
-0.00+45.95%
-0.00-13.15%
-0.00+0.09%
-0.00-15.41%
-0.00-14.26%
-0.00-21.25%
-0.01—
Access this data via the Eulerpool API

Amyris Stock analysis

What does Amyris do? Amyris Inc. is a US-based company specializing in the production of sustainable products. It was founded in 2003 and is headquartered in Emeryville, California. The company aims to promote sustainability in daily life and reduce dependence on fossil fuels. Amyris' business model is based on the discovery and development of biological microorganisms capable of converting sugars and other carbohydrates into valuable products such as fuels, chemicals, and flavors. This technology, known as synthetic biology, was first used for the production of artemisinin, which is used against malaria. Over time, Amyris has expanded its portfolio and specialized in the production of sustainable products for the cosmetics, biofuel, food, and chemical industries. Leading products include Biosolve, an environmentally friendly degreasing solution for the industry, Neossance, a plant-based moisturizer for the cosmetics industry, and Biofene, a bio-based fuel. To produce its products, the company has formed partnerships with various organizations around the world. For example, it has partnered with Total, a French oil and gas company, to establish joint ventures for the production of biofuels. Amyris has also expanded its business by developing a platform for synthetic biology that allows other industry players to develop custom organisms for production processes. This new business model has brought the company into new markets such as the medical and energy sectors. In 2020, the COVID-19 pandemic posed challenges for the company as demand for some products declined. In response, Amyris shifted its production to disinfectants to meet the increased demand for these products. Overall, Amyris has become a leading company in sustainable production and is committed to promoting innovations in synthetic biology to have a positive impact on the environment. Amyris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amyris stock

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Amyris since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Amyris with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Amyris

All Key Metrics — Amyris